A seven days course of eflornithine for relapsing Trypanosoma brucei gambiense sleeping sickness

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 91, Issue 2, 1997, Pages 212-213

  Khonde, N ^a,b   Pepin J ^a,c   Mpia, B ^b  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b Zone de Santé Rurale de Nioki   (South Africa)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

Author keywords

African trypanosomiasis; Chemotherapy; Eflornithine; Melarsoprol; Trypanosoma brucei gambiense; Zaire

Indexed keywords

ANTITRYPANOSOMAL AGENT; EFLORNITHINE;

ADULT; AFRICAN TRYPANOSOMIASIS; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; MALE; MORTALITY; RECURRENT DISEASE; TRYPANOSOMA;

TRYPANOSOMA; TRYPANOSOMA BRUCEI GAMBIENSE;

EID: 0030911962     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(97)90228-5     Document Type: Article

References (7)

1. Bacchi, C. J., Nathan, H. C., Clarkson, A. B., Bienen, E. J., Bitonti, A. J., McCann, P. P. & Sjoerdsma, A. (1987). Effect of ornithine decarboxylase inhibitors DL-α-difluoromethylornithine and α-monofluoromethyldehydroornithine methyl ester alone and in combination with suramin against Trypanosoma brucei brucei central nervous system models. American Journal of Tropical Medicine and Hygiene, 33, 46-52.
2. Hardenberg, J., Claverie, N. & Tell, G. P. (1991). Eflornithine (Ornidyl) treatment of Trypanosoma brucei gambiense sleeping sickness; report of 711 patients treated up to March 1991. International Scientific Council for Trypanosomiasis Research and Control Meeting, Yamoussoukro, October 1991, abstract no. 412A.
3. Jennings, F. W. (1990). Future prospects for the chemotherapy of human trypanosomiasis. 2. Combination therapy and African trypanosomiasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 84, 618-621.
4. Milord, F., Pépin, J., Loko, L., Ethier, L. & Mpia, B. (1992). Efficacy and toxicity of eflornithine for treatment of Trypanosoma brucei gambiense sleeping sickness. Lancet, 340, 652-655.
5. Milord, F., Loko, L., Éthier, L,. Mpia, B. & Pépin, J. (1993). Eflornithine concentrations in serum and cerebrospinal fluid of 63 patients treated for Trypanosoma brucei gambiense sleeping sickness. Transactions of the Royal Society of Tropical Medicine and Hygiene, 87, 473-477.
6. Philip, K. A., Dascombe, M. J., Fraser, P. A. & Pentreath, V. W. (1994). Blood-brain barrier damage in experimental African trypanosomiasis. Annals of Tropical Medicine and Parasitology, 88, 607-616.
7. Simarro, P. P. & Asumu, P. N. (1996). Gambian trypanosomiasis and synergism between melarsoprol and eflornithine: first case report. Transactions of the Royal Society of Tropical Medicine and Hygiene, 90, 315.